SCORE2 Outperforms Pol-SCORE in Detecting Increased Cardiovascular Risk
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Population
2.2. Cardiovascular Risk Assessment Tools
2.3. Clinical and Biochemical Measurements
2.4. Study Objectives
2.5. Statistical Analysis
2.6. Ethical Considerations
3. Results
Characteristics of the Respondents
4. Discussion
- The use of two validated cardiovascular risk assessment models (Pol-SCORE and SCORE2) in the same cohort, which allows for a direct comparison of their performance;
- The focus on a unique and under-researched population (military personnel and civilian employees of the armed forces), where cardiovascular health is of particular importance;
- The standardized assessment of major cardiovascular risk factors, including blood pressure, lipid profile, BMI, and self-reported lifestyle and stress indicators;
- The relevance of the findings for both clinical practice and occupational medicine, providing evidence that may inform future preventive strategies in the armed forces.
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Gielerak, G.; Krzesiński, P.; Piotrowicz, K.; Murawski, P.; Skrobowski, A.; Stańczyk, A.; Galas, A.; Uziębło-Życzkowska, B.; Kaźmierczak-Dziuk, A.; Maksimczuk, J.; et al. The Prevalence of Cardiovascular Risk Factors among Polish Soldiers: The Results from the MIL-SCORE Program. Cardiol. Res. Pract. 2020, 2020, 1–7. [Google Scholar] [CrossRef]
- Di Cesare, M.; Perel, P.; Taylor, S.; Kabudula, C.; Bixby, H.; Gaziano, T.A.; McGhie, D.V.; Mwangi, J.; Pervan, B.; Narula, J.; et al. The Heart of the World. Glob. Heart 2024, 19, 11. [Google Scholar] [CrossRef] [PubMed]
- Yusuf, S.; Hawken, S.; Ôunpuu, S.; Dans, T.; Avezum, A.; Lanas, F.; McQueen, M.; Budaj, A.; Pais, P.; Varigos, J.; et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004, 364, 937–952. [Google Scholar] [CrossRef] [PubMed]
- Perone, F.; Bernardi, M.; Spadafora, L.; Betti, M.; Cacciatore, S.; Saia, F.; Fogacci, F.; Jaiswal, V.; Asher, E.; Paneni, F.; et al. Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications. J. Cardiovasc. Dev. Dis. 2025, 12, 171. [Google Scholar] [CrossRef] [PubMed]
- Polska Akademia Nauk. Antynomie Systemu Ochrony Zdrowia; Polska Akademia Nauk: Warszawa, Poland, 2021; pp. 113–122. [Google Scholar]
- Agencja Oceny Technologii Medycznych i Taryfikacji. Rekomendacja nr 1/2023 Prezesa AOTMiT z 29 Grudnia 2023 r. w Sprawie Zalecanych Technologii Medycznych, Działań Przeprowadzanych w Ramach Programów Polityki Zdrowotnej Oraz Warunków Realizacji Tych Programów, Dotyczących Profilaktyki Uzależnień od Tytoniu (Nikotyny). 2023. Available online: https://www.aotm.gov.pl (accessed on 18 July 2025).
- Martin, S.S.; Aday, A.W.; Almarzooq, Z.I.; Anderson, C.A.; Arora, P.; Avery, C.L.; Baker-Smith, C.M.; Gibbs, B.B.; Beaton, A.Z.; Boehme, A.K.; et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation 2024, 149, E347–E913. [Google Scholar] [CrossRef]
- Lach, J.; Bzdęga, J.; Kubiak, L.; Ostalska, J.; Żbikowski, J.; Nieporęcki, R. Wojskowe zakłady lecznicze armii polskiej. Część I. Chorzy leczeni w latach 1922–1931 na podstawie sprawozdania gen. Stanisława Roupperta do Marszałka Józefa Piłsudskiego. Hygeia Public Health 2014, 49, 774–778. [Google Scholar]
- Trzeciak, B.G.; Kowalczyk, W.; Grymek, S.; Gutknecht, P.; Siebert, J. Cardiovascular risk factors among Polish employees of uniformed services. Int. J. Occup. Med. Environ. Health 2023, 36, 656–671. [Google Scholar] [CrossRef]
- Vemu, P.L.; Yang, E.; Ebinger, J. 2023 ESH Hypertension Guideline Update: Bringing Us Closer Together Across the Pond; American College of Cardiology: Washington, DC, USA, 2024; Available online: https://www.acc.org/Latest-in-Cardiology/Articles/2024/02/05/11/43/2023-ESH-Hypertension-Guideline-Update (accessed on 18 July 2025).
- Vrints, C.; Andreotti, F.; Koskinas, K.C.; Rossello, X.; Adamo, M.; Ainslie, J.; Banning, A.P.; Budaj, A.; Buechel, R.R.; Chiariello, G.A.; et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur. Heart J. 2024, 45, 3415–3564. [Google Scholar] [CrossRef]
- De Backer, G. European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). Eur. Heart J. 2003, 24, 1601–1610. [Google Scholar]
- Conroy, R. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 2003, 24, 987–1003. [Google Scholar] [CrossRef]
- SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 2021, 42, 2439–2454. [Google Scholar]
- Zdrojewski, T.; Jankowski, P.; Bandosz, P.; Bartuś, S.; Chwojnicki, K.; Drygas, W.; Gaciong, Z.; Hoffman, P.; Kalarus, Z.; Kaźmierczak, J.; et al. A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population. Kardiol. Pol. 2015, 73, 958–961. [Google Scholar] [CrossRef] [PubMed]
- Csenteri, O.; Jancsó, Z.; Szöllösi, G.J.; Andréka, P.; Vajer, P. Differences of cardiovascular risk assessment in clinical practice using SCORE and SCORE2. Open Heart 2022, 9, e002087. [Google Scholar] [CrossRef] [PubMed]
- Boskovic, N.; Giga, V.; Djordjevic-Dikic, A.; Beleslin, B.; Stojkovic, S.; Nedeljkovic, I.; Aleksandric, S.; Tesic, M.; Dedic, S.; Burazor, I.; et al. Comparison of SCORE and SCORE 2 risk prediction tools in contemporary very high risk european population. Eur. Heart J. 2022, 43 (Suppl. S2), ehac544.2281. [Google Scholar] [CrossRef]
- Rzepka-Cholasinska, A.; Kasprzak, M.; Michalski, P.; Pietrzykowski, Ł.; Grzelakowska, K.; Kubica, A. Cardiovascular risk assessment based on SCORE and SCORE2. Med. Res. J. 2022, 7, 164–169. [Google Scholar] [CrossRef]
- Selmer, R.; Lindman, A.S.; Tverdal, A.; Pedersen, J.I.; Njølstad, I.; Veierød, M.B. Modell for estimering av kardiovaskulaer risiko i Norge. Tidsskr. Laegeforen 2008, 128, 286–290. [Google Scholar]
- Svinin, G.E.; Kutsenko, V.A.; Shalnova, S.A.; Yarovaya, E.B.; Imaeva, A.E.; Balanova, Y.A.; Kapustina, A.V.; Muromtseva, G.A.; Drapkina, O.M. Validation of SCORE2 on a sample from the Russian population and adaptation for the very high cardiovascular disease risk region. PLoS ONE 2024, 19, e0300974. [Google Scholar]
- Vincent, S.R.; Schlenk, M.A.; Horan, K.A.; Moore, B.A. Incidences and trends of cardiovascular determinants and diagnoses in active duty service members. J. Mil. Veterans Health 2024, 32, 42–51. [Google Scholar]
- Pavlík, V.; Šafka, V.; Pravdová, L.; Urban, M.; Lašák, P.; Tuček, M. Comparison of selected risk factors in cardiovascular diseases in two different populations of the Czech Republic. Cent. Eur. J. Public Health 2020, 28, S47–S52. [Google Scholar] [CrossRef]
- Zimmerman, F.H. Cardiovascular Disease and Risk Factors in Law Enforcement Personnel: A Comprehensive Review. Cardiol. Rev. 2012, 20, 159–166. [Google Scholar] [CrossRef]
- Gendron, P.; Lajoie, C.; Laurencelle, L.; Trudeau, F. Cardiovascular health profile among Québec male and female police officers. Arch. Environ. Occup. Health 2019, 74, 331–340. [Google Scholar] [CrossRef] [PubMed]
- Zawadzka, M.; Marszałkowska-Jakubik, J.; Ejchman-Pac, E.; Pająk-Tarnacka, B.; Szymański, P. Assessing Cardiovascular Risk Among Polish Soldiers: Insights Using the POL SCORE Tool. J. Clin. Med. 2025, 14, 2130. [Google Scholar] [CrossRef] [PubMed]
- Vaicaitiene, R.; Cerniauskiene, L.R.; Luksiene, D.I.; Margeviciene, L. Hypercholesterolemia and Smoking Habits of Lithuanian Military Personnel. Mil. Med. 2006, 171, 512–515. [Google Scholar] [CrossRef] [PubMed]
- TVN24. MON do Żołnierzy: Rzućcie Palenie. 2011. Available online: https://tvn24.pl/polska/mon-do-zolnierzy-rzuccie-palenie-ra188270-ls3537014 (accessed on 18 July 2025).
- INFOR. W Obiektach MON Będzie Można Używać Wyrobów Tytoniowych Tylko w Palarniach. W Pojazdach Trzeba Będzie Zapytać o Zgodę Pasażerów. 2024. Available online: https://www.infor.pl/prawo/sluzby-mundurowe/wojsko/6573853,w-obiektach-mon-bedzie-mozna-uzywac-wyrobow-tytoniowych-tylko-w-palarn.html (accessed on 18 July 2025).
- Webber, B.J.; Bornstein, D.B.; Kiel, M.A.; Wilkins, R.C.; Bryant, C.X. Physical Activity and the Health of a Nation: A National Challenge and Collective Response. Am. J. Lifestyle Med. 2024, 18, 632–637. [Google Scholar] [CrossRef]
- Santos, A.R.D.; Ihlenfeld, M.F.K.; Olandoski, M.; Barreto, F.C. Comparative analysis of the health status of military police officers and firefighters: A cross-sectional study in the State of Paraná, Brazil. BMJ Open 2022, 12, e049182. [Google Scholar] [CrossRef]
- World Obesity Atlas 2023. 17 World Obesity Federation. 2023. Available online: https://worldobesity.org/resources/resource-library/world-obesity-atlas-2023 (accessed on 18 July 2025).
- American Security Project. Combating Military Obesity: Understanding the Problem and Developing Solutions. American Security Project: Washington, DC, USA, 2023; Available online: https://www.americansecurityproject.org/wp-content/uploads/2023/10/Ref-0286-Combating-Military-Obesity.pdf (accessed on 18 July 2025).
- Rosellini, A.J.; Stein, M.B.; Benedek, D.M.; Bliese, P.D.; Chiu, W.T.; Hwang, I.; Monahan, J.; Nock, M.K.; Petukhova, M.V.; Sampson, N.A.; et al. Using self-report surveys at the beginning of service to develop multi-outcome risk models for new soldiers in the U.S. Army. Psychol. Med. 2017, 47, 2275–2287. [Google Scholar] [CrossRef]
- McBride, D.; Samaranayaka, A.; Richardson, A.; Gardner, D.; Shepherd, D.; Wyeth, E.; de Graaf, B.; Derrett, S. Factors associated with self-reported health among New Zealand military veterans: A cross-sectional study. BMJ Open 2022, 12, e056916. [Google Scholar] [CrossRef]
Guideline Differences | 2017 ACC/AHA | 2024 ESC/ESH |
---|---|---|
hypertension definition | ≥130/80 | ≥130/80 |
normal BP ranges (mmHg) | Normal: <120/80 Elevated: 120–129/<80 | Optimal: <120/80 Normal: 120–129/80–84 High–Normal: 130–139/85–89 |
hypertensive BP ranges (mmHg) | Hypertension Stage 1: 130–139/80–89 Hypertension Stage 2: ≥140/90 | Hypertension Grade 1: 14–159/90–99 Hypertension Grade 2: 160–179/100–109 Hypertension Grade 3: ≥180/110 |
BP targets for treatment | ||
18–64 years (mmHg) | <130/80 | <130/80 |
65–79 years (mmHg) | <130/80 | <140/80 |
≥80 years (mmHg) | <130/80 | 140–150/<80 |
Variables | SD | Me | Min | Max | |||
---|---|---|---|---|---|---|---|
TOTAL | systolic blood pressure | 138.98 | 15.96 | 136.00 | 104.00 | 190.00 | |
total cholesterol | 231.01 | 44.79 | 225.00 | 121.00 | 459.60 | ||
non-HDL cholesterol | 169.10 | 44.60 | 168.00 | 50.00 | 380.20 | ||
age | 47.83 | 5.32 | 47.00 | 40.00 | 67.00 | ||
Pol-SCORE | LOW | systolic blood pressure | 131.69 | 9.02 | 132.5 | 115.00 | 145.00 |
total cholesterol | 212.6 | 31.77 | 203.00 | 172.20 | 304.00 | ||
non-HDL cholesterol | 145.49 | 33.28 | 139.65 | 94.10 | 235.00 | ||
age | 42.19 | 1.60 | 43.00 | 40.00 | 44.00 | ||
MODERATE | systolic blood pressure | 135.69 | 13.99 | 135.00 | 104.00 | 170.00 | |
total cholesterol | 228.69 | 46.45 | 228.00 | 121.00 | 459.60 | ||
non-HDL cholesterol | 166.00 | 45.22 | 166.00 | 50.00 | 380.00 | ||
age | 46.98 | 4.71 | 46.00 | 40.00 | 67.00 | ||
HIGH | systolic blood pressure | 149.04 | 17.59 | 150.00 | 114.00 | 190.00 | |
total cholesterol | 240.64 | 40.78 | 234.85 | 167.00 | 321.00 | ||
non-HDL cholesterol | 183.07 | 40.42 | 182.65 | 107.7 | 253.00 | ||
age | 51.07 | 4.38 | 51.00 | 40.00 | 64.00 | ||
VERY HIGH | systolic blood pressure | 157.00 | 15.69 | 150.00 | 140.00 | 189.00 | |
total cholesterol | 258.60 | 44.85 | 268.00 | 185.60 | 323.60 | ||
non-HDL cholesterol | 197.10 | 49.54 | 209.00 | 110.70 | 248.60 | ||
age | 57.00 | 5.50 | 56.00 | 51.00 | 67.00 | ||
SCORE2 | LOW | systolic blood pressure | 131.94 | 11.60 | 133.00 | 104.00 | 170.00 |
total cholesterol | 225.09 | 43.97 | 220.00 | 121.00 | 340.00 | ||
non-HDL cholesterol | 154.80 | 41.68 | 153.00 | 50.00 | 273.00 | ||
age | 47.09 | 4.82 | 46.00 | 40.00 | 59.00 | ||
HIGH | systolic blood pressure | 144.29 | 16.67 | 142.00 | 112.00 | 190.00 | |
total cholesterol | 232.17 | 45.66 | 222.20 | 130.00 | 459.60 | ||
non-HDL cholesterol | 176.56 | 42.89 | 170.10 | 75.00 | 380.20 | ||
age | 47.74 | 5.43 | 47.00 | 40.00 | 67.00 | ||
VERY HIGH | systolic blood pressure | 151.06 | 16.24 | 150.00 | 119.00 | 189.00 | |
total cholesterol | 259.06 | 34.67 | 265.00 | 168.00 | 323.60 | ||
non-HDL cholesterol | 211.65 | 33.78 | 216.20 | 135.00 | 253.00 | ||
age | 52.50 | 5.42 | 52.00 | 43.00 | 67.00 |
Variables | Pol-SCORE | SCORE2 | ||||||
---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Very High | Low | High | Very High | ||
gender [%] | male | - | 66.43 | 28.57 | 5.00 | 33.57 | 55.71 | 10.72 |
female | 28.57 | 67.86 | 3.57 | - | 82.14 | 16.07 | 1.79 | |
study group [%] | soldier | 10.53 | 74.34 | 14.47 | 0.66 | 59.21 | 38.82 | 1.97 |
civilian worker | 40.91 | - | 45.45 | 13.64 | 6.82 | 63.64 | 29.55 | |
military services corps [%] | private soldier | 12.50 | 62.50 | 25.00 | - | 25.00 | 75.00 | - |
non-commissioned oficer | 5.68 | 63.64 | 28.41 | 2.27 | 37.50 | 53.41 | 9.09 | |
junior oficer | 5.00 | 70.00 | 20.00 | 5.00 | 50.00 | 45.00 | 5.00 | |
senior oficer | 2.94 | 67.65 | 20.59 | 8.82 | 38.24 | 44.12 | 17.64 | |
general, admiral | - | 66.67 | 33.33 | - | 66.67 | 33.33 | - | |
none | 18.60 | 72.09 | 6.98 | 2.33 | 76.74 | 20.93 | 2.33 |
Variables | Pol-SCORE | SCORE2 | ||||||
---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Very High | Low | High | Very High | ||
self-awareness in preventing cardiovascular diseases | yes | 86.67 | 92.31 | 97.62 | 100.00 | 92.39 | 93.02 | 100.00 |
no | 13.33 | 7.69 | 2.38 | - | 7.61 | 6.98 | - |
Variables | Pol-SCORE | SCORE2 | ||||||
---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Very High | Low | High | Very High | ||
occurrence of cardiovascular diseases in the family | yes | 66.67 | 48.82 | 35.72 | 42.86 | 51.11 | 45.88 | 31.25 |
no | 20.00 | 34.65 | 54.76 | 42.86 | 31.11 | 43.53 | 50.00 | |
no opinion | 13.33 | 16.53 | 9.52 | 14.28 | 17.78 | 10.59 | 18.75 |
Variables | Pol-SCORE | SCORE2 | ||||||
---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Very High | Low | High | Very High | ||
chest pain | yes | 6.67 | 10.24 | 4.76 | - | 11.11 | 7.06 | - |
no | 93.33 | 89.76 | 95.24 | 100.00 | 88.89 | 92.94 | 100.00 | |
Statistics | H = 1.973; p = 0.5778 | H = 2.518; p = 0.2839 | ||||||
dyspnoea | Yes | 13.33 | 6.30 | 2.38 | 14.29 | 8.89 | 2.35 | 12.50 |
No | 86.67 | 93.70 | 97.62 | 85.71 | 91.11 | 97.65 | 87.50 | |
Statistics | H = 3.097; p = 0.3768 | H = 4.295; p = 0.1168 | ||||||
dizziness | Yes | - | 8.66 | 4.76 | - | 7.78 | 5.88 | 6.25 |
No | 100.00 | 91.34 | 95.24 | 100.00 | 92.22 | 94.12 | 93.75 | |
Statistics | H = 2.559; p = 0.4647 | H = 0.254; p = 0.8804 | ||||||
heart palpitations | Yes | 13.33 | 14.17 | 7.14 | 28.57 | 15.56 | 10.59 | 12.50 |
No | 86.67 | 85.83 | 92.86 | 71.43 | 84.44 | 89.41 | 87.50 | |
Statistics | H = 2.897; p = 0.4078 | H = 0.948; p = 0.6224 | ||||||
pain in the lower limbs | Yes | 6.67 | 13.39 | 7.14 | 14.29 | 15.56 | 5.88 | 18.75 |
No | 93.33 | 86.61 | 92.86 | 85.71 | 84.44 | 94.12 | 81.25 | |
Statistics | H = 1.614; p = 0.6562 | H = 4.883; p = 0.0870 | ||||||
headache | Yes | 60.00 | 35.43 | 26.19 | 14.29 | 42.22 | 24.71 | 43.75 |
No | 40.00 | 64.57 | 73.81 | 85.71 | 57.78 | 75.29 | 56.25 | |
Statistics | H = 6.872; p = 0.0761 | H = 6.549; p = 0.0378 | ||||||
increased blood pressure | Yes | - | 24.41 | 30.95 | 28.57 | 16.67 | 32.94 | 18.75 |
No | 100.00 | 75.59 | 69.05 | 71.43 | 83.33 | 67.06 | 81.25 | |
Statistics | H = 5.895; p = 0.1168 | H = 6.569; p = 0.0374 |
Variables | Pol-SCORE | SCORE2 | ||||||
---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Very High | Low | High | Very High | ||
overweight | Yes | 14.29 | 34.15 | 40.48 | 28.57 | 27.91 | 36.09 | 50.00 |
No | 85.71 | 65.85 | 59.52 | 71.43 | 72.09 | 63.10 | 50.00 | |
statistics | H = 3.289; p = 0.3491 | H = 3.549; p = 0.1695 | ||||||
obesity | Yes | 14.29 | 14.63 | 26.19 | 14.29 | 13.95 | 16.67 | 37.50 |
No | 85.71 | 85.37 | 73.81 | 85.71 | 86.05 | 83.33 | 62.50 | |
statistics | H = 3.060; p = 0.3824 | H = 5.253; p = 0.0723 | ||||||
incorrect diet | Yes | 42.86 | 41.46 | 47.62 | 42.86 | 40.70 | 41.67 | 62.50 |
No | 57.14 | 58.54 | 52.38 | 57.14 | 59.30 | 58.33 | 37.50 | |
statistics | H = 0.481; p = 0.9229 | H = 2.714; p = 0.2574 | ||||||
increased cholesterol levels | Yes | 7.14 | 15.45 | 38.10 | 14.29 | 11.63 | 22.62 | 50.00 |
No | 92.86 | 84.55 | 61.90 | 85.71 | 88.37 | 77.38 | 50.00 | |
statistics | H = 11.760; p = 0.0082 | H = 13.108; p = 0.0014 | ||||||
low physical activity | Yes | 35.71 | 20.33 | 28.57 | 14.29 | 25.58 | 16.67 | 43.75 |
No | 64.29 | 79.67 | 71.43 | 85.71 | 74.42 | 83.33 | 56.25 | |
statistics | H = 2.784; p = 0.4261 | H = 6.059; p = 0.0483 | ||||||
smoking | Yes | 7.14 | 17.07 | 45.24 | 28.57 | 8.14 | 30.95 | 62.50 |
No | 92.86 | 82.93 | 54.76 | 71.43 | 91.86 | 69.05 | 37.50 | |
statistics | H = 16.131; p = 0.0011 | H = 27.569; p = 0.0000 | ||||||
drinking alcohol | Yes | 7.14 | 17.07 | 30.95 | 14.29 | 15.12 | 20.24 | 37.50 |
No | 92.86 | 82.93 | 69.05 | 85.71 | 84.88 | 79.76 | 62.50 | |
statistics | H = 5.452; p = 0.1415 | H = 4.383; p = 0.1117 | ||||||
stress | Yes | 71.43 | 59.35 | 54.76 | 28.57 | 60.47 | 55.95 | 56.25 |
no | 28.57 | 40.65 | 45.24 | 71.43 | 39.53 | 44.05 | 43.75 | |
statistics | H = 3.778; p = 0.2864 | H = 0.377; p = 0.8282 |
Variables | Pol-SCORE | SCORE2 | ||||||
---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Very High | Low | High | Very High | ||
self-assessment of health | very good | 26.67 | 18.03 | 16.67 | 28.57 | 18.60 | 19.05 | 18.75 |
good | 53.33 | 59.84 | 61.90 | 42.86 | 58.14 | 60.72 | 56.25 | |
sufficient | 13.33 | 10.66 | 11.90 | 28.57 | 10.47 | 11.90 | 18.75 | |
poor | - | 0.81 | - | - | 1.16 | - | - | |
no opinion | 6.67 | 10.66 | 9.53 | - | 11.63 | 8.33 | 6.25 |
Variables | Pol-SCORE | SCORE2 | ||||||
---|---|---|---|---|---|---|---|---|
Low | Moderate | High | Very High | Low | High | Very High | ||
frequency of preventive tests for cardiovascular diseases | more than once a year | - | 8.13 | 2.38 | - | 8.05 | 4.76 | - |
once a year | 6.67 | 23.57 | 42.86 | 57.14 | 18.39 | 35.71 | 37.50 | |
once every 5 years | 13.33 | 12.20 | 9.52 | 28.57 | 13.79 | 10.71 | 12.50 | |
when I have symptoms | 20.00 | 8.13 | 4.76 | - | 8.05 | 8.33 | 6.25 | |
only periodic tests at work | 46.67 | 42.28 | 40.48 | 14.29 | 45.98 | 35.71 | 43.75 | |
I do not get tested | 13.33 | 5.69 | - | - | 5.74 | 4.76 | - |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zawadzka, M.; Ejchman-Pac, E.; Kowalska, A.; Szymański, P.; Marszałkowska-Jakubik, J. SCORE2 Outperforms Pol-SCORE in Detecting Increased Cardiovascular Risk. Pathophysiology 2025, 32, 45. https://doi.org/10.3390/pathophysiology32030045
Zawadzka M, Ejchman-Pac E, Kowalska A, Szymański P, Marszałkowska-Jakubik J. SCORE2 Outperforms Pol-SCORE in Detecting Increased Cardiovascular Risk. Pathophysiology. 2025; 32(3):45. https://doi.org/10.3390/pathophysiology32030045
Chicago/Turabian StyleZawadzka, Magdalena, Ewelina Ejchman-Pac, Amelia Kowalska, Paweł Szymański, and Justyna Marszałkowska-Jakubik. 2025. "SCORE2 Outperforms Pol-SCORE in Detecting Increased Cardiovascular Risk" Pathophysiology 32, no. 3: 45. https://doi.org/10.3390/pathophysiology32030045
APA StyleZawadzka, M., Ejchman-Pac, E., Kowalska, A., Szymański, P., & Marszałkowska-Jakubik, J. (2025). SCORE2 Outperforms Pol-SCORE in Detecting Increased Cardiovascular Risk. Pathophysiology, 32(3), 45. https://doi.org/10.3390/pathophysiology32030045